Dear AuntMinnieEurope Member,
Medical technology companies must do far more to provide radiologists with the all-important data they need to strengthen their arguments for increased funding and recruitment. That's the main conclusion of an important new report from the Royal College of Radiologists.
The document contains practical hints and pointers that are of general value and applicability, so it's relevant beyond just the U.K. medical imaging community. Best of all, you can download it for free.
COVID-19 is still widely regarded as a pulmonary infection, but it's essential to consider new discoveries related to the vascular aspects of the disease, asserts Dutch cardiac imaging expert Prof. Dr. Matthijs Oudkerk, PhD. He calls for a well-informed discussion about the optimal use of CT in the pandemic. Learn more in the CT Community.
When a patient arrives from the emergency department or hospital ward for a contrast-enhanced CT scan without appropriate intravenous (IV) access, often the result is a delay in diagnosis and patient management. A U.K. audit has found inappropriate IV access occurred in around 7.5% of cases, and the authors have proposed a five-point plan of action.
Any research conducted at the world-famous German Cancer Research Center (DKFZ) deserves a close look. You won't want to miss our news report about the DKFZ's latest experiences of hybrid imaging in patients with pancreatic ductal adenocarcinoma. Visit the Molecular Imaging Community for more on this story.
Last but not least, new evidence came on 5 November of the type of changes being made by industry as a result of the pandemic. Declining demand for computed radiography (CR) systems is prompting Agfa HealthCare to shift production away from its CR manufacturing facilities in Germany in favor of China.
